CD40 and colitis: Notably, pharmacological inhibition of CD40 signaling significantly attenuated Fn-aggravated colitis, as evidenced by less body weight loss (Figure 7B), reduced DAI scores (Figure 7C), preserved colon length (Figures 7D, E), and improved histological features (Figures 7F, G).